FDA clears Abbott Libre Duo as 1st glucose ketone device
Abbott's Libre Duo 10 Day has received FDA authorization, making it the first device to continuously track both glucose and ketone levels for people with diabetes as young as two.
Worn for up to 10 days, it gives users a fuller picture of their health: no more one-off tests.
Libre Duo sends real-time ketone alerts
Real-time alerts let users know if their ketones are rising, helping them spot early signs of diabetic ketoacidosis (DKA), which can be serious.
Abbott's Chris Scoggins, executive vice president of Abbott's diabetes care business, puts it simply: "If glucose is the speedometer, ketones are like the check engine light, providing an alert that something may need attention," so you and your caregivers can react quickly.
Plus, the device connects with the Libre app now and will soon work with automated insulin systems, making diabetes management even smoother.